CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).

Setiawan, Veronica Wendy

CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). [electronic resource] - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology Nov 2007 - 2237-46 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural

1055-9965

10.1158/1055-9965.EPI-07-0589 doi


Breast Neoplasms--enzymology
Case-Control Studies
Cohort Studies
Cooperative Behavior
Female
Genetic Predisposition to Disease
Genetic Variation
Gonadal Steroid Hormones--metabolism
Haplotypes
Humans
Male
Mutation, Missense
Polymorphism, Single Nucleotide
Postmenopause--metabolism
Prostatic Neoplasms--enzymology
Steroid 17-alpha-Hydroxylase--genetics